Nebulizer

Global Smart Inhalers Market (2020 to 2025) - by Components, Product, Application, Distribution Channel, End-use and Geography

Retrieved on: 
Tuesday, April 20, 2021

Amongst the two, the solutions segment is estimated to hold the highest market share.\nBy Product, the market is classified as inhalers and nebulizers.

Key Points: 
  • Amongst the two, the solutions segment is estimated to hold the highest market share.\nBy Product, the market is classified as inhalers and nebulizers.
  • Amongst the two, the inhalers segment is estimated to hold the highest market share.\nBy Application, the market is classified as asthma and chronic obstructive pulmonary disease (COPD).
  • Amongst the two, the asthma segment is estimated to hold the highest market share.\nBy Distribution Channel, the market is classified as hospital pharmacies, retail pharmacies, and online channels.
  • Amongst all, hospital pharmacies are estimated to hold the highest market share.\nBy End Use, the market is classified as patients, R&D, and others.

Worldwide Portable Compressor Nebulizer Industry to 2025 - Increasing Demand for Home Healthcare Devices Presents Opportunities

Retrieved on: 
Tuesday, April 20, 2021

In Nov 2018, Koninklijke Philips launched InnoSpire Go portable nebulizer in the U.S.

Key Points: 
  • In Nov 2018, Koninklijke Philips launched InnoSpire Go portable nebulizer in the U.S.
  • The product is the smallest and lightest portable handheld nebulizer.\n2.
  • In October 2018, Pari Pharma gets approval for its e-FLOW technology device LAMIRA, which is the only nebulizer system to deliver amikacin liposome inhalation suspension (ARIKAYCE).
  • The projections are calculated using proven research methodologies.\nThe report has been compiled through extensive primary and secondary research.

Outlook on the Digital Respiratory Devices Global Market to 2030 - Focus on Sensors, Smart Inhalers & Nebulizers, Application, Countries and Competitive Landscape

Retrieved on: 
Monday, April 19, 2021

b"The Global Digital Respiratory Devices Market is projected to reach $405.1 million by 2030.

Key Points: 
  • b"The Global Digital Respiratory Devices Market is projected to reach $405.1 million by 2030.
  • The study also provides exhaustive information on competitive landscape, brand share landscape, market share of the leading players, as well as other vital information with respect to the global digital respiratory devices market.
  • The report considers sensors and apps, and smart inhalers and nebulizers.\nSome of the key players contributing to the Global Digital Respiratory Devices Market include 3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Cognita Labs, Cohero Health, Findair Sp.
  • z. o. o, GlaxoSmithKline plc, Novartis AG, Pneuma Respiratory, Propeller Health, Sensiron AG, and Teva Pharmaceuticals Industries Ltd.\nHow pharmaceutical companies are capitalizing on the opportunity for connected inhalers to improve drug sales?\nWhat has been the impact of the COVID-19 pandemic on global digital respiratory devices market?\nWhat are the potential recovery scenarios of the market from the COVID-19 pandemic, and how can it impact the market forecast?\nHow will the pharma industry evolve in terms of drug-based devices in the future?\nWhat are the potential business models in global digital respiratory devices market?\nWhat are the major market drivers, challenges, and opportunities in the global digital respiratory devices market?\nWhat are the underlying structures resulting in the emerging trends within the digital respiratory devices industry?\nWhat was the market value of the leading segments and sub-segments of the global digital respiratory devices market in 2021?\nHow is each segment of the global digital respiratory devices market expected to grow during the forecast period and what is the revenue anticipated to be generated by each of the segments by the end of 2030?\nWhat are the influencing factors that may affect the market share of the key players?\nWhat is the market share of each of the companies in the global digital respiratory devices market and what are their contributions?\nHow can market intelligence on digital respiratory device add value to an organization's decision-making process?\n"

Worldwide Digital Respiratory Devices Industry to 2030 - Treatment Satisfaction with Inhaled Therapy Among Individuals is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 14, 2021

b"The Global Digital Respiratory Devices Market is projected to reach $405.1 million by 2030.

Key Points: 
  • b"The Global Digital Respiratory Devices Market is projected to reach $405.1 million by 2030.
  • The study highlights that the market is set to witness a CAGR of 27.31% between 2021 and 2030.\nThis comprehensive study of the global digital respiratory devices market covers the following:\nBesides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, end-user analysis, and COVID-19 impact on the market.\nThe study indicates that increasing prevalence of respiratory diseases, increasing adoption of digital technology among individuals, and treatment satisfaction with inhaled therapy among individuals are fueling the growth of the market.\nThe study highlights the various emerging opportunities, such as expansion into the emerging markets and predicting future exacerbations, which can be leveraged by players operating in the market.\nThe purpose of the study is to enable the reader to gain a holistic view of the Global Digital Respiratory Devices Market.\nThe report constitutes an in-depth analysis of the global digital respiratory devices market, including a thorough analysis of the different end-users.
  • The study also provides exhaustive information on competitive landscape, brand share landscape, market share of the leading players, as well as other vital information with respect to the global digital respiratory devices market.
  • The report considers sensors and apps, and smart inhalers and nebulizers.\nHow pharmaceutical companies are capitalizing on the opportunity for connected inhalers to improve drug sales?\nWhat has been the impact of the COVID-19 pandemic on global digital respiratory devices market?\nWhat are the potential recovery scenarios of the market from the COVID-19 pandemic, and how can it impact the market forecast?\nHow will the pharma industry evolve in terms of drug-based devices in the future?\nWhat are the potential business models in global digital respiratory devices market?\nWhat are the major market drivers, challenges, and opportunities in the global digital respiratory devices market?\nWhat are the underlying structures resulting in the emerging trends within the digital respiratory devices industry?\nWhat was the market value of the leading segments and sub-segments of the global digital respiratory devices market in 2021?\nHow is each segment of the global digital respiratory devices market expected to grow during the forecast period and what is the revenue anticipated to be generated by each of the segments by the end of 2030?\nWhat are the influencing factors that may affect the market share of the key players?\nWhat is the market share of each of the companies in the global digital respiratory devices market and what are their contributions?\nHow can market intelligence on digital respiratory device add value to an organization's decision-making process?\n"

Global Metered Dose Inhaler Devices Pipeline Assessment Report 2020 - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 8, 2021

The "Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.
  • "Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Metered Dose Inhaler Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
  • Metered Dose Inhaler Devices delivers a specific amount of medication to lungs and GI tract.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
    In-depth analysis of the product's current stage of development, territory and estimated launch date

OMRON Healthcare, Asthma and Allergy Foundation of America (AAFA) Join Together to Provide More Respiratory Medical Care to Underserved Communities

Retrieved on: 
Wednesday, March 31, 2021

OMRON's support will also help AAFA deliver educational information to communities most in need of more resources.

Key Points: 
  • OMRON's support will also help AAFA deliver educational information to communities most in need of more resources.
  • Respiratory care products like nebulizers play a critical role in asthma management," said OMRON Healthcare president and CEO, Ranndy Kellogg.
  • Black, Hispanic, Indigenous Americans and other minority groups face the highest burden of asthma because of the impact of health disparities3.
  • OMRON's donated nebulizers will reach underserved communities nationwide and expand access to asthma management technology.

Worldwide Portable Compressor Nebulizer Industry to 2025 - Increasing Demand for Home Healthcare Devices Presents Opportunities

Retrieved on: 
Tuesday, March 23, 2021

This research report categorizes the Portable Compressor Nebulizer to forecast the revenues and analyze the trends in each of the following sub-markets:

Key Points: 
  • This research report categorizes the Portable Compressor Nebulizer to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Type, the Portable Compressor Nebulizer Market is examined across Mesh Nebulizer, Pneumatic Nebulizer, and Ultrasonic Nebulizer.
  • Based on Geography, the Portable Compressor Nebulizer Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa.
  • What are the technology trends and regulatory frameworks in the Global Portable Compressor Nebulizer Market?
  • What are the modes and strategic moves considered suitable for entering the Global Portable Compressor Nebulizer Market?

India Drug Delivery Devices Market Forecast & Opportunities, FY2026: Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch) & Route of Administration (Oral Drug Delivery, Injectable Drug Delivery) - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 23, 2021

The "India Drug Delivery Devices Market, By Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch), By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Others), By Patient Care Setting, By Application, By Region, By Region, Forecast & Opportunities, FY2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "India Drug Delivery Devices Market, By Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch), By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Others), By Patient Care Setting, By Application, By Region, By Region, Forecast & Opportunities, FY2026" report has been added to ResearchAndMarkets.com's offering.
  • The Indian Drug Delivery Devices Market was valued at around USD564 million in FY2020 and is expected to grow at a steady CAGR of 8.05% during the forecast period.
  • The Indian Drug Delivery Devices Market is driven by growing use of drug delivery systems in healthcare facilities.
  • The Indian Drug Delivery Devices Market is segmented based on devices, route of administration, patient care setting, application, company, and region.

Global Portable Compressor Nebulizer Market Research Report (2020 to 2025) - by Type, Distribution Channel and Application - ResearchAndMarkets.com

Retrieved on: 
Friday, March 19, 2021

What is the market size and forecast of the Global Portable Compressor Nebulizer Market?

Key Points: 
  • What is the market size and forecast of the Global Portable Compressor Nebulizer Market?
  • What are the inhibiting factors and impact of COVID-19 shaping the Global Portable Compressor Nebulizer Market during the forecast period?
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Portable Compressor Nebulizer Market?
  • What are the modes and strategic moves considered suitable for entering the Global Portable Compressor Nebulizer Market?

Lisa Deschamps Joins Verona Pharma as Non-Executive Director

Retrieved on: 
Tuesday, March 2, 2021

Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs.

Key Points: 
  • Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs.
  • The Company is evaluating nebulized ensifentrine in its Phase 3 clinical program ENHANCE (Ensifentrine as a Novel inHAled Nebulized COPD thErapy) for COPD maintenance treatment.
  • All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements.
  • These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.